At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Explorations of Neurofeedback Issues in ADHD
In Brief
A clinical study evaluating Active Neurofeedback and Sham neurofeedback for Attention Deficit Hyperactivity Disorder. Completed, enrolled 39 participants across 1 site.
Detailed Summary
Neurofeedback is increasingly advocated for treatment of ADHD despite a thin evidence base. The numerous open and partially controlled studies suffer serious design flaws. In particular, there is no published double-blind randomized clinical trial (RCT), which would control for experimenter and participant biases. The primary aim of this R34 pilot study is to conduct a small-scale pilot with 39 8-12 year-olds with ADHD to prepare for such a larger RCT.
Study Details
Timeline
Interventions
A comparison of active neurofeedback to sham neurofeedback and of two treatment schedules: twice weekly vs. three times a week, with the same amount of total treatment over 40 sessions, varying only in frequency.
Active neurofeedback vs. sham neurofeedback for 40 treatments, either twice or three times per week.